Retrospective Analysis of Speech Performance Using the HiRes Ultra and HiRes Ultra 3D Cochlear Implant
Launched by ADVANCED BIONICS AG · Mar 4, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well two types of cochlear implants, called HiRes Ultra and HiRes Ultra 3D, help people understand speech. The study is gathering information from individuals who have already received these implants to see how effectively they can hear and understand conversations. It's important because it helps confirm how well these devices perform in real-life situations.
To participate in this trial, you need to be someone who has either one or two HiRes Ultra or HiRes Ultra 3D cochlear implants. This includes those who have recently received a new HiRes Ultra implant or those who had a previous version that stopped working. There are no specific exclusions, so if you meet these criteria and provide informed consent, you may be eligible to join the study. Participants can expect to share their experiences with the device and contribute to valuable research that can help improve hearing solutions for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Unilateral or bilateral HiRes Ultra CI or HiRes Ultra 3D CI users including
- • Ultra Version V2 newly implanted on this side (Group 1)
- • Ultra Version V2 users implanted following an Ultra Version V1 device failure in the same ear (Group 2)
- • Informed consent signed
- Exclusion Criteria:
- • no exclusion criteria
About Advanced Bionics Ag
Advanced Bionics AG is a leading global medical device company specializing in innovative cochlear implant technology and neurostimulation solutions. Committed to enhancing the quality of life for individuals with hearing loss and neurological disorders, the company focuses on advanced research and development, clinical trials, and cutting-edge product design. With a strong emphasis on patient-centered care and collaboration with healthcare professionals, Advanced Bionics AG aims to deliver groundbreaking solutions that improve auditory experiences and neurological outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hannover, , Germany
Patients applied
Trial Officials
Andreas Büchner
Principal Investigator
Hannover Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported